Drug Targeting and Design

Special Issues

Following special issues within this section are currently open for submissions:

• Advances in Mitochondria-Targeted Drug Delivery (Deadline: 15 April 2023)
• Tropical Protozoan Disease Treatment Drugs (Deadline: 20 April 2023)
• Recent Advances in Antiviral Drug Development (Deadline: 30 April 2023)
• Recent Advances in Biotechnological Applications of Microbial Surfactants (Deadline: 30 April 2023)
• Biomaterials and Agents: Pharmaceutical and Biomedical Applications in Dental Research (Deadline: 30 April 2023)
• Drugs and Drug Delivery for Diabetes Mellitus Treatment (Deadline: 10 May 2023)
• Peptide-Based Drugs for Cancer Therapies (Deadline: 10 May 2023)
• Recent Advances in Antibacterial Drugs: Focus on Peptides and Their Compounds (Deadline: 10 May 2023)
• Metallodrugs: Investigation of the Mechanism of Action and Advanced Delivery Systems at Molecular Level (Deadline: 20 May 2023)
• Application of Peptide-Drug-Conjugates in the Treatment of Cancer and Microbial Infections (Deadline: 20 May 2023)
• Development of Novel Pharmaceuticals for the Treatment of Parasitic Diseases (Deadline: 20 May 2023)
• Targeted Therapies in Diabetes and Its Complications (Deadline: 20 May 2023)
• Designing Nanomaterials for Drug Delivery and Cancer-Targeted Therapy (Deadline: 20 May 2023)
• Emerging Anti-cancer and Cellular Targets and Their Mechanism(s) of Action as New Tools for Therapeutics Approaches (Deadline: 20 May 2023)
• State of the Art of Membrane Active Peptides (Deadline: 20 May 2023)
• Nanozymes for Anti-cancer and Anti-bacterial Treatment (Deadline: 30 May 2023)
• Drug Stability: Factors and New Approaches to Overcome Drug Instability (Deadline: 30 May 2023)
• Current and Future Cancer Chemoprevention Strategies, Volume II (Deadline: 31 May 2023)
• Dose Optimization and Targeting Strategies of Anti-infective Agents (Deadline: 31 May 2023)
• Drug Targeting towards Fighting Pathogen Bacteria (Deadline: 31 May 2023)
• Biodegradable Nanomaterials for Targeted Drug Delivery (Deadline: 31 May 2023)
• Recent Advances in Radiopharmacy (Deadline: 31 May 2023)
• Novel Therapeutic Targets and Drug Development in Retinal Diseases (Deadline: 10 June 2023)
• Radiopharmaceuticals for Cancer Imaging and Therapy (Deadline: 20 June 2023)
• Computer Simulation for Drug Design and Medical Bioengineering (Deadline: 30 June 2023)
• Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders (Deadline: 30 June 2023)
• Advances in Drug Targeting for Central Nervous System Disease (Deadline: 30 June 2023)
• New Discoveries in Drug Targets and Delivery for Alzheimer’s Disease (Deadline: 30 June 2023)
• Recent Advances in the Development of Hybrid Drugs (Deadline: 30 June 2023)
• Light-Assisted Precision Medicine: Nanodrug, Bioimaging and Biosensor (Deadline: 30 June 2023)
• Molecular Imaging of the Immune System (Deadline: 30 June 2023)
• Recent Advances in Therapeutic Strategies for the Treatment of Pediatric Diseases (Deadline: 30 June 2023)
• New Insights into Targeted Therapy of Solid Tumors with Polymeric Nanoparticles (Deadline: 30 June 2023)
• Salmonella: A Promising Tool in Vaccine Development and Cancer Therapy (Deadline: 30 June 2023)
• Beyond the Platinum in Metal-Based Cancer Therapy (Volume II) (Deadline: 20 July 2023)
• Recent Advances in Anticancer Photodynamic Therapy (Deadline: 30 July 2023)
• New Approaches to Drug Discovery and Targeted Therapy (Deadline: 30 July 2023)
• Advances in Anticancer Agent (Deadline: 31 July 2023)
• Host-Direct Immunotherapy and Antivirulence Therapy to Combat Microbial Infections (Deadline: 31 July 2023)
• Drug Candidates and Drug Delivery Systems for Tuberculosis Treatment (Deadline: 31 July 2023)
• Drug Development and Treatment for Neurological Disease (Deadline: 31 July 2023)
• Anticancer Drug Targeting Using Novel Delivery Systems and Medical Devices (Deadline: 31 July 2023)
• Current State-of-Art of Extracellular Vesicles for Targeting Gene Therapy in Neurological Disorders (Deadline: 31 July 2023)
• New Insights on Drug Design, Delivery and Targeting in Neurodegeneration (Deadline: 31 July 2023)
• Advanced Nanopharmaceutics for Anticancer Therapy (Deadline: 10 August 2023)
• Targeted Therapies in Cardiovascular and Kidney Diseases (Deadline: 20 August 2023)
• Drug Transporters: Regulation and Roles in Therapeutic Strategies (Deadline: 31 August 2023)
• Recent Advances in Drug Therapy for Malaria (Deadline: 31 August 2023)
• Advances in the Development and Application of Targeted Radiopharmaceuticals for Cancer Management (Volume II) (Deadline: 31 August 2023)
• Application Prospect of Hydrogels in the Treatment of Osteochondral Lesions (Deadline: 31 August 2023)
• Promising Small Molecule Compounds in Cancer Treatment (Deadline: 31 August 2023)
• Research on Therapeutic Prodrugs for Targeted Cancer Therapy (Deadline: 31 August 2023)
• Diabetes Mellitus: Promising Molecules, Drug Modification, Formulations, and Therapy (Deadline: 31 August 2023)
• Delivery of Anticancer Drugs (Deadline: 10 September 2023)
• Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development (Volume II) (Deadline: 30 September 2023)
• Role of Proteomics in Drug Development and Delivery (Deadline: 30 September 2023)
• RNA-Targeted Drug Design, Discovery and Delivery: A Treasure Trove of Novel Therapeutic Opportunities (Deadline: 30 September 2023)
• Recent Progress in Reactive Oxygen Species-Related Therapy for Disease Treatment (Deadline: 30 September 2023)
• Advancements in Novel Nanomaterials for Cancer Therapy and Diagnosis (Deadline: 30 September 2023)
• Photodynamic Therapy in Cancer: Principles, State of the Art, and Future Directions (Deadline: 15 October 2023)
• Antimicrobial Peptides of the Innate Immune System as Multifunctional Molecules and Promising Drugs (Deadline: 20 October 2023)
• Role of ABC Transporters in Drug Development (Deadline: 30 October 2023)
• Novel Drugs, Targets and Therapies against Infectious Diseases (Deadline: 31 October 2023)
• Targeted Therapies for Skin Diseases (Deadline: 30 November 2023)
• Prodrugs and Molecular Hybrids as Innovative Strategies in Medicinal Chemistry (Deadline: 31 December 2023)
• Novel Approaches in the Search for Active Compounds in Drug Discovery and Development (Deadline: 1 April 2024)